US Edition
AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs - AstraZeneca (NASDAQ:AZN)
AstraZeneca’s $4.5 billion investment will create 3,600 direct and indirect jobs, supporting U.S. drug manufacturing and advancing cancer and metabolic treatment production.
- On Oct. 9, 2025, AstraZeneca broke ground near Charlottesville at the Rivanna Futures site, announcing a $4.5 billion investment that Pascal Soriot said anchors a $50 billion U.S. plan.
- AstraZeneca said it chose Virginia for its strong talent, research proximity and `pro-business environment`, while the Virginia Economic Development Partnership and Albemarle County used a $9.7 million Business Ready Sites grant to prepare Rivanna Futures site.
- The Virginia build spans two capabilities: drug‑substance production for weight‑management and metabolic portfolios and a separate antibody‑drug conjugate manufacturing facility producing oral GLP‑1, baxdrostat, oral PCSK9 and small‑molecule products using AI, automation and data analytics.
- The project will create 600 highly skilled jobs and roughly 3,000 construction roles, with first production targeted in four to five years and about 3,600 direct and indirect jobs eventually.
- Seen through a policy lens, the project aligns with an onshoring push by the administration following a White House tariff threat on Sept. 25 of 100% tariffs and officials framing it as strengthening national security and health sovereignty.
25 Articles
25 Articles
The Virginian Pilot
Daily PressAstraZeneca breaks ground on $4.5 billion plant in Virginia
Construction is now underway on a $4.5 billion manufacturing facility for pharmaceutical giant AstraZeneca in Albemarle County, which promises to bring some 600 jobs to Central Virginia. Gov. Glenn Youngkin, Trump administration officials, county leaders and AstraZeneca’s CEO broke ground on the plant Thursday. “This isn’t just an economic development announcement,” Youngkin said at the ground-breaking. “This is a transformational moment for Alb…
Pharma Giant To Make Largest-Ever Investment In United States
Pharmaceutical industry company AstraZeneca plans to invest $4.5 billion on two manufacturing facilities in Virginia. The project, which is the British-Swedish corporation’s largest-ever investment, is projected to create about 600 jobs. The investment is estimated to create about 3,000 additional indirect jobs. “Today we announced our plans to invest $4.5 billion in a new manufacturing facility in Virginia. This includes a proposed $500m increa…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
